Kejako develops a non-invasive solution for interested presbyopic patients seeking to keep their quality of life.
Kejako has raised $789K in total funding. The most recent round was Seed. The last funding was announced in August 2022.
Kejako's investors include MassChallenge, FONGIT, Business Angels Switzerland (BAS).
Kejako is headquartered in Geneve, Switzerland.
Kejako develops a non-invasive solution for interested presbyopic patients seeking to keep their quality of life.
Kejako is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kejako — Funding & Investors." VCBacked, August 1, 2022, https://www.vcbacked.co/company/kejako. Accessed August 14, 2026.
VCBacked. (2022). Kejako — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/kejako
{{cite web |title=Kejako — Funding & Investors |url=https://www.vcbacked.co/company/kejako |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated